Catalent Inc at JPMorgan Healthcare Conference Transcript
All right. Let's get started. Good afternoon, everyone. Welcome to day 1 afternoon of the JPMorgan Healthcare Conference. I'm Julia Qin, lead analyst covering life science tools and diagnostics at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Catalent. And now with that, let me turn it over to them.
Thank you, Julia. Afternoon, everyone. Welcome, and very glad to be here to present the Catalent story. Before we get started, before we begin, I would like to call your attention to Page 2 and 3 of our presentation with regards to our use of forward-looking statements and non-GAAP financial measures as well as I would like to invite you to read our SEC filings with regard of risks and uncertainty that can bear our future operating results and our financial conditions. With that said, let me start from our mission, right?
At Catalent, we have a very, very clear mission, which is to help people
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |